Loading…

Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40

1 SCA40 (1nm − 10 μm), isoprenaline (1–300 nm) and levcromakalim (100 nm − 10 μm) each produced concentration‐dependent suppression of the spontaneous tone of guinea‐pig isolated trachea. Propranolol (1 μm) markedly (approximately 150 fold) antagonized isoprenaline but did not antagonize SCA40. The...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 1995-01, Vol.114 (1), p.143-151
Main Authors: Cook, S.J., Archer, K., Martin, A., Buchheit, K.H., Fozard, J.R., Müller, T., Miller, A.J., Elliott, K.R.F., Foster, R.W., Small, R.C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5078-4964d29649aecd6fbac620c8c30473e8e0e438ee249363fa4569e4baff6f5a013
cites cdi_FETCH-LOGICAL-c5078-4964d29649aecd6fbac620c8c30473e8e0e438ee249363fa4569e4baff6f5a013
container_end_page 151
container_issue 1
container_start_page 143
container_title British journal of pharmacology
container_volume 114
creator Cook, S.J.
Archer, K.
Martin, A.
Buchheit, K.H.
Fozard, J.R.
Müller, T.
Miller, A.J.
Elliott, K.R.F.
Foster, R.W.
Small, R.C.
description 1 SCA40 (1nm − 10 μm), isoprenaline (1–300 nm) and levcromakalim (100 nm − 10 μm) each produced concentration‐dependent suppression of the spontaneous tone of guinea‐pig isolated trachea. Propranolol (1 μm) markedly (approximately 150 fold) antagonized isoprenaline but did not antagonize SCA40. The tracheal relaxant action of SCA40 was unaffected by suramin (100 μm) or 8‐(p)‐sulphophenyltheophylline (8‐SPT; 140 μm). 2 An isosmolar, K+‐rich (80 mm) Krebs solution increased tracheal tone, antagonized SCA40 (approximately 60 fold), antagonized isoprenaline (approximately 20 fold) and very profoundly depressed the log concentration‐effect curve for levcromakalim. Nifedipine (1 μm) did not itself modify the relaxant actions of SCA40, isoprenaline or levcromakalim. However, nifedipine prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by the K+‐rich medium. In contrast, nifedipine did not prevent the equivalent antagonism of levcromakalim. 3 Charybdotoxin (100 nm) increased tracheal tone, antagonized SCA40 (approximately 4 fold) and antagonized isoprenaline (approximately 3 fold). Nifedipine (1 μm) prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by charybdotoxin. 4 Quinine (30 μm) caused little or no change in tissue tone and did not modify the relaxant action of isoprenaline. However, quinine antagonized SCA40 (approximately 2 fold). Nifedipine (1 μm) prevented the antagonism of SCA40 induced by quinine. 5 Tested on spontaneously‐beating guinea‐pig isolated atria SCA40 (1 nm − 10 μm) increased the rate of beating in a concentration‐dependent manner. Over the concentration‐range 1 μm − 10 μm, SCA40 also caused an increase in the force of atrial contraction. 6 Intracellular electrophysiological recording from guinea‐pig isolated trachealis showed that the relaxant effects of SCA40 (1 μm) were often accompanied by the suppression of spontaneous electrical slow waves but no change in resting membrane potential. When the concentration of SCA40 was raised to 10 μm, its relaxant activity was accompanied both by slow wave suppression and by plasmalemmal hyperpolarization. 7 SCA40 (10 nm − 100 μm) more potently inhibited the activity of cyclic AMP phosphodiesterase (PDE) than that of cyclic GMP PDE derived from homogenates of guinea‐pig trachealis. Theophylline (1 μm − 10 mm) also inhibited these enzymes but was less potent than SCA40 in each case and did not exhibit selectivity for inhibition of
doi_str_mv 10.1111/j.1476-5381.1995.tb14918.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1510160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77208238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5078-4964d29649aecd6fbac620c8c30473e8e0e438ee249363fa4569e4baff6f5a013</originalsourceid><addsrcrecordid>eNqVUV1v0zAUtRDT6AY_ASlCiLdkduw4Dg-IrWIMaRJIg2fr1r1ZXTnOsJOt_fc4a1TBI36wLZ8PH91DyDtGC5bWxbZgopZ5xRUrWNNUxbBiomGq2L0giyP0kiwopXXOmFKvyFmMW0oTWFen5LSuWUkZXZC76zEMGwwZeHD7aGPWt1l6yDo0G_A2djEb_RqD21t__4wMAcwGwWUBHezADxmYwfZ-Ut4tLwV9TU5acBHfzOc5-XX95efyJr_9_vXb8vI2NxWtVS4aKdZl2hpAs5btCowsqVGGU1FzVEhRcIVYioZL3oKoZINiBW0r2woo4-fk08H3YVx1uDboUzSnH4LtIOx1D1b_i3i70ff9o2YVo0zSZPBhNgj97xHjoDsbDToHHvsx6rouqSq5SsSPB6IJfYwB2-MnjOqpEr3V09z1NHc9VaLnSvQuid_-HfMonTtI-PsZh2jAtQG8sfFI40IKqUSifT7QnqzD_X8E0Fc_bp6v_A_5GKpo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77208238</pqid></control><display><type>article</type><title>Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40</title><source>Open Access: PubMed Central</source><creator>Cook, S.J. ; Archer, K. ; Martin, A. ; Buchheit, K.H. ; Fozard, J.R. ; Müller, T. ; Miller, A.J. ; Elliott, K.R.F. ; Foster, R.W. ; Small, R.C.</creator><creatorcontrib>Cook, S.J. ; Archer, K. ; Martin, A. ; Buchheit, K.H. ; Fozard, J.R. ; Müller, T. ; Miller, A.J. ; Elliott, K.R.F. ; Foster, R.W. ; Small, R.C.</creatorcontrib><description>1 SCA40 (1nm − 10 μm), isoprenaline (1–300 nm) and levcromakalim (100 nm − 10 μm) each produced concentration‐dependent suppression of the spontaneous tone of guinea‐pig isolated trachea. Propranolol (1 μm) markedly (approximately 150 fold) antagonized isoprenaline but did not antagonize SCA40. The tracheal relaxant action of SCA40 was unaffected by suramin (100 μm) or 8‐(p)‐sulphophenyltheophylline (8‐SPT; 140 μm). 2 An isosmolar, K+‐rich (80 mm) Krebs solution increased tracheal tone, antagonized SCA40 (approximately 60 fold), antagonized isoprenaline (approximately 20 fold) and very profoundly depressed the log concentration‐effect curve for levcromakalim. Nifedipine (1 μm) did not itself modify the relaxant actions of SCA40, isoprenaline or levcromakalim. However, nifedipine prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by the K+‐rich medium. In contrast, nifedipine did not prevent the equivalent antagonism of levcromakalim. 3 Charybdotoxin (100 nm) increased tracheal tone, antagonized SCA40 (approximately 4 fold) and antagonized isoprenaline (approximately 3 fold). Nifedipine (1 μm) prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by charybdotoxin. 4 Quinine (30 μm) caused little or no change in tissue tone and did not modify the relaxant action of isoprenaline. However, quinine antagonized SCA40 (approximately 2 fold). Nifedipine (1 μm) prevented the antagonism of SCA40 induced by quinine. 5 Tested on spontaneously‐beating guinea‐pig isolated atria SCA40 (1 nm − 10 μm) increased the rate of beating in a concentration‐dependent manner. Over the concentration‐range 1 μm − 10 μm, SCA40 also caused an increase in the force of atrial contraction. 6 Intracellular electrophysiological recording from guinea‐pig isolated trachealis showed that the relaxant effects of SCA40 (1 μm) were often accompanied by the suppression of spontaneous electrical slow waves but no change in resting membrane potential. When the concentration of SCA40 was raised to 10 μm, its relaxant activity was accompanied both by slow wave suppression and by plasmalemmal hyperpolarization. 7 SCA40 (10 nm − 100 μm) more potently inhibited the activity of cyclic AMP phosphodiesterase (PDE) than that of cyclic GMP PDE derived from homogenates of guinea‐pig trachealis. Theophylline (1 μm − 10 mm) also inhibited these enzymes but was less potent than SCA40 in each case and did not exhibit selectivity for inhibition of cyclic AMP hydrolysis. 8 Tested against the activity of the isoenzymes of cyclic nucleotide PDE derived from human blood cells and lung tissue, SCA40 proved highly potent against the type III isoenzyme. It was markedly less potent against the type IV and type V isoenzymes and even less potent against the isoenzymes types I and II. 9 It is concluded that the tracheal relaxant action of SCA40 (1 nm − 1 μm) does not involve the activation of β‐adrenoceptors or P1 or P2 purinoceptors. Furthermore, this action is unlikely to depend upon the opening of BKCa channels with consequent cellular hyperpolarization and voltage‐dependent inhibition of Ca2+ influx. The tracheal relaxant action of SCA40 (up to 1 μm) is more likely to depend upon its selective inhibition of the type III isoenzyme of cyclic nucleotide PDE. At concentrations above 1 μm, SCA40 exerts more general inhibition of the isoenzymes of cyclic nucleotide PDE and may then promote the opening of BKCa channels.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1995.tb14918.x</identifier><identifier>PMID: 7712010</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Biological and medical sciences ; cardiac atrial muscle ; charybdotoxin ; Cyclic AMP - pharmacology ; cyclic nucleotide phosphodiesterase ; Electric Stimulation ; Electrophysiology ; Female ; Guinea Pigs ; Imidazoles - pharmacology ; isoprenaline ; Isoproterenol - pharmacology ; K+‐rich Krebs solution ; levcromakalim ; Male ; Medical sciences ; nifedipine ; Nifedipine - pharmacology ; Parasympatholytics - pharmacology ; Pharmacology. Drug treatments ; Pyrazines - pharmacology ; quinine ; Quinine - pharmacology ; Respiratory system ; SCA40 ; Theophylline - pharmacology ; Trachea - drug effects ; Trachealis muscle</subject><ispartof>British journal of pharmacology, 1995-01, Vol.114 (1), p.143-151</ispartof><rights>1995 British Pharmacological Society</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5078-4964d29649aecd6fbac620c8c30473e8e0e438ee249363fa4569e4baff6f5a013</citedby><cites>FETCH-LOGICAL-c5078-4964d29649aecd6fbac620c8c30473e8e0e438ee249363fa4569e4baff6f5a013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510160/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510160/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3464684$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7712010$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cook, S.J.</creatorcontrib><creatorcontrib>Archer, K.</creatorcontrib><creatorcontrib>Martin, A.</creatorcontrib><creatorcontrib>Buchheit, K.H.</creatorcontrib><creatorcontrib>Fozard, J.R.</creatorcontrib><creatorcontrib>Müller, T.</creatorcontrib><creatorcontrib>Miller, A.J.</creatorcontrib><creatorcontrib>Elliott, K.R.F.</creatorcontrib><creatorcontrib>Foster, R.W.</creatorcontrib><creatorcontrib>Small, R.C.</creatorcontrib><title>Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 SCA40 (1nm − 10 μm), isoprenaline (1–300 nm) and levcromakalim (100 nm − 10 μm) each produced concentration‐dependent suppression of the spontaneous tone of guinea‐pig isolated trachea. Propranolol (1 μm) markedly (approximately 150 fold) antagonized isoprenaline but did not antagonize SCA40. The tracheal relaxant action of SCA40 was unaffected by suramin (100 μm) or 8‐(p)‐sulphophenyltheophylline (8‐SPT; 140 μm). 2 An isosmolar, K+‐rich (80 mm) Krebs solution increased tracheal tone, antagonized SCA40 (approximately 60 fold), antagonized isoprenaline (approximately 20 fold) and very profoundly depressed the log concentration‐effect curve for levcromakalim. Nifedipine (1 μm) did not itself modify the relaxant actions of SCA40, isoprenaline or levcromakalim. However, nifedipine prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by the K+‐rich medium. In contrast, nifedipine did not prevent the equivalent antagonism of levcromakalim. 3 Charybdotoxin (100 nm) increased tracheal tone, antagonized SCA40 (approximately 4 fold) and antagonized isoprenaline (approximately 3 fold). Nifedipine (1 μm) prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by charybdotoxin. 4 Quinine (30 μm) caused little or no change in tissue tone and did not modify the relaxant action of isoprenaline. However, quinine antagonized SCA40 (approximately 2 fold). Nifedipine (1 μm) prevented the antagonism of SCA40 induced by quinine. 5 Tested on spontaneously‐beating guinea‐pig isolated atria SCA40 (1 nm − 10 μm) increased the rate of beating in a concentration‐dependent manner. Over the concentration‐range 1 μm − 10 μm, SCA40 also caused an increase in the force of atrial contraction. 6 Intracellular electrophysiological recording from guinea‐pig isolated trachealis showed that the relaxant effects of SCA40 (1 μm) were often accompanied by the suppression of spontaneous electrical slow waves but no change in resting membrane potential. When the concentration of SCA40 was raised to 10 μm, its relaxant activity was accompanied both by slow wave suppression and by plasmalemmal hyperpolarization. 7 SCA40 (10 nm − 100 μm) more potently inhibited the activity of cyclic AMP phosphodiesterase (PDE) than that of cyclic GMP PDE derived from homogenates of guinea‐pig trachealis. Theophylline (1 μm − 10 mm) also inhibited these enzymes but was less potent than SCA40 in each case and did not exhibit selectivity for inhibition of cyclic AMP hydrolysis. 8 Tested against the activity of the isoenzymes of cyclic nucleotide PDE derived from human blood cells and lung tissue, SCA40 proved highly potent against the type III isoenzyme. It was markedly less potent against the type IV and type V isoenzymes and even less potent against the isoenzymes types I and II. 9 It is concluded that the tracheal relaxant action of SCA40 (1 nm − 1 μm) does not involve the activation of β‐adrenoceptors or P1 or P2 purinoceptors. Furthermore, this action is unlikely to depend upon the opening of BKCa channels with consequent cellular hyperpolarization and voltage‐dependent inhibition of Ca2+ influx. The tracheal relaxant action of SCA40 (up to 1 μm) is more likely to depend upon its selective inhibition of the type III isoenzyme of cyclic nucleotide PDE. At concentrations above 1 μm, SCA40 exerts more general inhibition of the isoenzymes of cyclic nucleotide PDE and may then promote the opening of BKCa channels.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>cardiac atrial muscle</subject><subject>charybdotoxin</subject><subject>Cyclic AMP - pharmacology</subject><subject>cyclic nucleotide phosphodiesterase</subject><subject>Electric Stimulation</subject><subject>Electrophysiology</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Imidazoles - pharmacology</subject><subject>isoprenaline</subject><subject>Isoproterenol - pharmacology</subject><subject>K+‐rich Krebs solution</subject><subject>levcromakalim</subject><subject>Male</subject><subject>Medical sciences</subject><subject>nifedipine</subject><subject>Nifedipine - pharmacology</subject><subject>Parasympatholytics - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrazines - pharmacology</subject><subject>quinine</subject><subject>Quinine - pharmacology</subject><subject>Respiratory system</subject><subject>SCA40</subject><subject>Theophylline - pharmacology</subject><subject>Trachea - drug effects</subject><subject>Trachealis muscle</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqVUV1v0zAUtRDT6AY_ASlCiLdkduw4Dg-IrWIMaRJIg2fr1r1ZXTnOsJOt_fc4a1TBI36wLZ8PH91DyDtGC5bWxbZgopZ5xRUrWNNUxbBiomGq2L0giyP0kiwopXXOmFKvyFmMW0oTWFen5LSuWUkZXZC76zEMGwwZeHD7aGPWt1l6yDo0G_A2djEb_RqD21t__4wMAcwGwWUBHezADxmYwfZ-Ut4tLwV9TU5acBHfzOc5-XX95efyJr_9_vXb8vI2NxWtVS4aKdZl2hpAs5btCowsqVGGU1FzVEhRcIVYioZL3oKoZINiBW0r2woo4-fk08H3YVx1uDboUzSnH4LtIOx1D1b_i3i70ff9o2YVo0zSZPBhNgj97xHjoDsbDToHHvsx6rouqSq5SsSPB6IJfYwB2-MnjOqpEr3V09z1NHc9VaLnSvQuid_-HfMonTtI-PsZh2jAtQG8sfFI40IKqUSifT7QnqzD_X8E0Fc_bp6v_A_5GKpo</recordid><startdate>199501</startdate><enddate>199501</enddate><creator>Cook, S.J.</creator><creator>Archer, K.</creator><creator>Martin, A.</creator><creator>Buchheit, K.H.</creator><creator>Fozard, J.R.</creator><creator>Müller, T.</creator><creator>Miller, A.J.</creator><creator>Elliott, K.R.F.</creator><creator>Foster, R.W.</creator><creator>Small, R.C.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199501</creationdate><title>Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40</title><author>Cook, S.J. ; Archer, K. ; Martin, A. ; Buchheit, K.H. ; Fozard, J.R. ; Müller, T. ; Miller, A.J. ; Elliott, K.R.F. ; Foster, R.W. ; Small, R.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5078-4964d29649aecd6fbac620c8c30473e8e0e438ee249363fa4569e4baff6f5a013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>cardiac atrial muscle</topic><topic>charybdotoxin</topic><topic>Cyclic AMP - pharmacology</topic><topic>cyclic nucleotide phosphodiesterase</topic><topic>Electric Stimulation</topic><topic>Electrophysiology</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Imidazoles - pharmacology</topic><topic>isoprenaline</topic><topic>Isoproterenol - pharmacology</topic><topic>K+‐rich Krebs solution</topic><topic>levcromakalim</topic><topic>Male</topic><topic>Medical sciences</topic><topic>nifedipine</topic><topic>Nifedipine - pharmacology</topic><topic>Parasympatholytics - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrazines - pharmacology</topic><topic>quinine</topic><topic>Quinine - pharmacology</topic><topic>Respiratory system</topic><topic>SCA40</topic><topic>Theophylline - pharmacology</topic><topic>Trachea - drug effects</topic><topic>Trachealis muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cook, S.J.</creatorcontrib><creatorcontrib>Archer, K.</creatorcontrib><creatorcontrib>Martin, A.</creatorcontrib><creatorcontrib>Buchheit, K.H.</creatorcontrib><creatorcontrib>Fozard, J.R.</creatorcontrib><creatorcontrib>Müller, T.</creatorcontrib><creatorcontrib>Miller, A.J.</creatorcontrib><creatorcontrib>Elliott, K.R.F.</creatorcontrib><creatorcontrib>Foster, R.W.</creatorcontrib><creatorcontrib>Small, R.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cook, S.J.</au><au>Archer, K.</au><au>Martin, A.</au><au>Buchheit, K.H.</au><au>Fozard, J.R.</au><au>Müller, T.</au><au>Miller, A.J.</au><au>Elliott, K.R.F.</au><au>Foster, R.W.</au><au>Small, R.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1995-01</date><risdate>1995</risdate><volume>114</volume><issue>1</issue><spage>143</spage><epage>151</epage><pages>143-151</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 SCA40 (1nm − 10 μm), isoprenaline (1–300 nm) and levcromakalim (100 nm − 10 μm) each produced concentration‐dependent suppression of the spontaneous tone of guinea‐pig isolated trachea. Propranolol (1 μm) markedly (approximately 150 fold) antagonized isoprenaline but did not antagonize SCA40. The tracheal relaxant action of SCA40 was unaffected by suramin (100 μm) or 8‐(p)‐sulphophenyltheophylline (8‐SPT; 140 μm). 2 An isosmolar, K+‐rich (80 mm) Krebs solution increased tracheal tone, antagonized SCA40 (approximately 60 fold), antagonized isoprenaline (approximately 20 fold) and very profoundly depressed the log concentration‐effect curve for levcromakalim. Nifedipine (1 μm) did not itself modify the relaxant actions of SCA40, isoprenaline or levcromakalim. However, nifedipine prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by the K+‐rich medium. In contrast, nifedipine did not prevent the equivalent antagonism of levcromakalim. 3 Charybdotoxin (100 nm) increased tracheal tone, antagonized SCA40 (approximately 4 fold) and antagonized isoprenaline (approximately 3 fold). Nifedipine (1 μm) prevented the rise in tissue tone and the antagonism of SCA40 and isoprenaline induced by charybdotoxin. 4 Quinine (30 μm) caused little or no change in tissue tone and did not modify the relaxant action of isoprenaline. However, quinine antagonized SCA40 (approximately 2 fold). Nifedipine (1 μm) prevented the antagonism of SCA40 induced by quinine. 5 Tested on spontaneously‐beating guinea‐pig isolated atria SCA40 (1 nm − 10 μm) increased the rate of beating in a concentration‐dependent manner. Over the concentration‐range 1 μm − 10 μm, SCA40 also caused an increase in the force of atrial contraction. 6 Intracellular electrophysiological recording from guinea‐pig isolated trachealis showed that the relaxant effects of SCA40 (1 μm) were often accompanied by the suppression of spontaneous electrical slow waves but no change in resting membrane potential. When the concentration of SCA40 was raised to 10 μm, its relaxant activity was accompanied both by slow wave suppression and by plasmalemmal hyperpolarization. 7 SCA40 (10 nm − 100 μm) more potently inhibited the activity of cyclic AMP phosphodiesterase (PDE) than that of cyclic GMP PDE derived from homogenates of guinea‐pig trachealis. Theophylline (1 μm − 10 mm) also inhibited these enzymes but was less potent than SCA40 in each case and did not exhibit selectivity for inhibition of cyclic AMP hydrolysis. 8 Tested against the activity of the isoenzymes of cyclic nucleotide PDE derived from human blood cells and lung tissue, SCA40 proved highly potent against the type III isoenzyme. It was markedly less potent against the type IV and type V isoenzymes and even less potent against the isoenzymes types I and II. 9 It is concluded that the tracheal relaxant action of SCA40 (1 nm − 1 μm) does not involve the activation of β‐adrenoceptors or P1 or P2 purinoceptors. Furthermore, this action is unlikely to depend upon the opening of BKCa channels with consequent cellular hyperpolarization and voltage‐dependent inhibition of Ca2+ influx. The tracheal relaxant action of SCA40 (up to 1 μm) is more likely to depend upon its selective inhibition of the type III isoenzyme of cyclic nucleotide PDE. At concentrations above 1 μm, SCA40 exerts more general inhibition of the isoenzymes of cyclic nucleotide PDE and may then promote the opening of BKCa channels.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>7712010</pmid><doi>10.1111/j.1476-5381.1995.tb14918.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1995-01, Vol.114 (1), p.143-151
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1510160
source Open Access: PubMed Central
subjects Animals
Biological and medical sciences
cardiac atrial muscle
charybdotoxin
Cyclic AMP - pharmacology
cyclic nucleotide phosphodiesterase
Electric Stimulation
Electrophysiology
Female
Guinea Pigs
Imidazoles - pharmacology
isoprenaline
Isoproterenol - pharmacology
K+‐rich Krebs solution
levcromakalim
Male
Medical sciences
nifedipine
Nifedipine - pharmacology
Parasympatholytics - pharmacology
Pharmacology. Drug treatments
Pyrazines - pharmacology
quinine
Quinine - pharmacology
Respiratory system
SCA40
Theophylline - pharmacology
Trachea - drug effects
Trachealis muscle
title Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A17%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Further%20analysis%20of%20the%20mechanisms%20underlying%20the%20tracheal%20relaxant%20action%20of%20SCA40&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Cook,%20S.J.&rft.date=1995-01&rft.volume=114&rft.issue=1&rft.spage=143&rft.epage=151&rft.pages=143-151&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1995.tb14918.x&rft_dat=%3Cproquest_pubme%3E77208238%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5078-4964d29649aecd6fbac620c8c30473e8e0e438ee249363fa4569e4baff6f5a013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77208238&rft_id=info:pmid/7712010&rfr_iscdi=true